Salazar, Alfredo M.

HRN: 16-13-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/04/2026
03/10/2026
IV
500mg
Q8
T/c Encephalopathy Prob Septic Vs Metabolic
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominalUnspecified Sepsis    Compliance to guidelines: